Glepaglutide, a long-acting glp-2 analog, significantly reduces need for parenteral support in patients with short bowel syndrome: results of ease sbs-1, a randomized, doubleblind, 24-week phase 3 trial

GASTROENTEROLOGY(2023)

引用 0|浏览4
暂无评分
关键词
short bowel syndrome,glepaglutide,parenteral support,long-acting,double-blind
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要